CDC Recommendations for Flu Treatment and Prophylaxis

CDC recommends neuraminidase inhibitors

According to the Centers for Disease Control (CDC), neuraminidase inhibitors are:

• Recommended for the treatment and prophylaxis of influenza²
• Effective against both influenza type A and B²

CDC continues to recommend neuraminidase inhibitors

• Since the 2004-2005 flu season, neuraminidase inhibitors have been recommended each year²
• Over the same period, CDC has not recommended use of older antivirals (M2 Inhibitors) due to high resistance potential²

CDC recommends neuraminidase inhibitors for treatment and prevention of influenza
type A and B.

Next topic: Neuraminidase Inhibitors

• Impact of the Flu
• Flu Contagiousness
• Influenza Diagnosis
• CDC Recommendations for Flu Treatment and Prophylaxis
  • Neuraminidase Inhibitors
• Flu Surveillance
• Resource Center

• Impact of the Flu
• |
• Flu Contagiousness
• |
• Influenza Diagnosis
• |
• CDC Recommendations for Flu Treatment and Prophylaxis
• 
  
• Flu Surveillance
• |
• Resource Center
• |
• Contact Us
• |
• Genentech Antiviral Medication
• |
• fluFACTS.com Consumer Web site

© 2006-2010 Genentech USA, Inc. All rights reserved. This site is intended for U.S. residents only. Use and access of this site are subject to the terms and conditions as set out in our Legal Statement and Privacy Statement.